0001752724-23-054437.txt : 20230314 0001752724-23-054437.hdr.sgml : 20230314 20230314112219 ACCESSION NUMBER: 0001752724-23-054437 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 EFFECTIVENESS DATE: 20230314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY U.S. GOVERNMENT SECURITIES TRUST CENTRAL INDEX KEY: 0000730044 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-03870 FILM NUMBER: 23729685 BUSINESS ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 800-869-6397 MAIL ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY US GOVERNMENT SECURITIES TRUST DATE OF NAME CHANGE: 20010618 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY DEAN WITTER US GOVERNMENT SECURITIES TRUST DATE OF NAME CHANGE: 19980622 FORMER COMPANY: FORMER CONFORMED NAME: WITTER DEAN U S GOVERNMENT SECURITIES TRUST DATE OF NAME CHANGE: 19920703 0000730044 S000002426 Morgan Stanley US Government Securities Trust C000006467 A USGAX C000006469 L USGCX C000006470 I USGDX C000155939 Class C MSGVX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000730044 XXXXXXXX 811-03870 false false false N-1A S000002426 C000006467 C000006470 C000006469 C000155939 MORGAN STANLEY U.S. GOVERNMENT SECURITIES TRUST 811-03870 0000730044 5493009GJO3TMFRP8I30 522 FIFTH AVENUE NEW YORK 10036 US-NY US 800-869-6397 State Street Bank and Trust Company 1 Lincoln Street Boston 02111 617-786-3000 Custody and Accounting Records. N N N-1A 1 Y Frances L. Cashman N/A N Kathleen A. Dennis N/A N Michael F. Klein N/A N Dr. Manuel H. Johnson N/A N Patricia A. Maleski N/A N Nancy C. Everett N/A N Eddie A. Grier N/A N Jakki L. Haussler N/A N Joseph J. Kearns N/A N Frank L. Bowman N/A N W. Allen Reed N/A N Deidre A. Downes N/A 1633 Broadway New York 10019 XXXXXX N N N N N N Morgan Stanley Distribution, Inc. 8-44766 000030344 54930020DF0S7EF78K71 Y N Ernst & Young LLP 42 N/A N N N N N N N Morgan Stanley U.S. Government Securities Trust S000002426 5493009GJO3TMFRP8I30 N 4 0 0 N/A N N N N N/A N/A N/A Rule 22d-1 (17 CFR 270.22d-1) Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Morgan Stanley Investment Management Inc. 801-15757 000110353 6N8SC06AK49F0N7KIX52 N SS&C GIDS, Inc. 84-00448 21B7QCD05XOK0YTYOP98 N N Eaton Vance Management N/A 549300RJ0CSL5M1B7J96 Y N Y PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N ICE Data Services, Inc. 13-3668779 Tax ID N IHS Markit Ltd. 549300HLPTRASHS0E726 GB N Bloomberg L.P. 549300B56MD0ZC402L06 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Clearstream Banking S.A. 549300OL514RA0SXJJ44 LU N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) N Morgan Stanley Distribution, Inc. 54930020DF0S7EF78K71 Y N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N Y Morgan Stanley Investment Management Inc. 6N8SC06AK49F0N7KIX52 Y N N Morgan Stanley Canada Limited N/A N/A 54930065FO7CXEUTGL76 CA 0.00000000 Morgan Stanley India Company Private Limited N/A N/A OYO6KC46QF54MHNL5D43 IN 0.00000000 Morgan Stanley Corretora de Titulos e Valores Mobiliarios S.A. N/A N/A HN65QO5XTFJICDM5V937 BR 0.00000000 Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V. N/A N/A FHYNAGT8UJJJOGL0BI58 MX 0.00000000 Morgan Stanley Australia Securities Limited N/A N/A 6NYZXKE9GUP7XNI56S88 AU 0.00000000 AFS Securities, LLC 8-69483 000171819 549300UINHVGEOCZXA73 0.00000000 Eaton Vance Management (International) Limited N/A 000281469 549300HBYTOFMPCTSB79 GB 0.00000000 Morgan Stanley France N/A N/A PK168Q24DU7QQ2T4QF97 FR 0.00000000 Morgan Stanley Hong Kong Securities Limited N/A N/A 549300SY0QG9QQ09KW20 HK 0.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 0.00000000 Morgan Stanley Wealth Management Australia Pty Ltd N/A N/A 549300VR74G9RZHCCE31 AU 0.00000000 Fxglobalclear Limited N/A N/A N/A GB 0.00000000 Eaton Vance Distributors, Inc. 8-47939 000037731 5493008E3UZUI6J6EL94 0.00000000 Morgan Stanley Capital Group Inc. N/A N/A VB7RXNZGO6KVDABYB880 0.00000000 Morgan Stanley Bank, National Association N/A N/A G1MLHIS0N32I3QPILB75 0.00000000 Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. N/A N/A O7YCEUWQXFIO1CHULC69 JP 0.00000000 Morgan Stanley Distribution, Inc. 8-44766 000030344 54930020DF0S7EF78K71 0.00000000 CreditDeriv Limited N/A N/A N/A GB 0.00000000 Morgan Stanley S.V., S.A.U N/A N/A 549300GSKN0B8BOS5L68 ES 0.00000000 EOS Precious Metals Limited N/A N/A N/A GB 0.00000000 Morgan Stanley Europe SE N/A N/A 54930056FHWP7GIWYY08 DE 0.00000000 PT Morgan Stanley Sekuritas Indonesia N/A N/A 549300JVGZMY503T1I56 ID 0.00000000 Morgan Stanley Asia Limited N/A N/A 549300KZJFHUSUNKZZ03 HK 0.00000000 Equilend LLC 8-53738 000119107 213800BN4DRR1ADYGP92 0.00000000 Morgan Stanley Capital Products LLC N/A N/A IVNH9ABHJY5L0X3RKW69 0.00000000 E*TRADE Securities LLC 8-44112 000029106 549300PJRJFMBCDPWR57 0.00000000 Morgan Stanley Asia (Singapore) Securities Pte Ltd N/A N/A 549300JN2HN4WBKARP61 SG 0.00000000 OTCDeriv Limited N/A N/A 213800AJVXMIB2FPEM07 GB 0.00000000 Morgan Stanley MUFG Securities Co., Ltd. N/A N/A 549300OB5SQ53A8BTO30 JP 0.00000000 Morgan Stanley Taiwan Limited N/A N/A 549300UX7BN34UFIPA91 TW 0.00000000 Morgan Stanley & Co. International PLC N/A N/A 4PQUHN3JPFGFNF3BB653 GB 0.00000000 MorganStanley Menkul Degerler Anonim Sirketi N/A N/A 549300VJZV93UIORC566 TR 0.00000000 Morgan Stanley Asia (Singapore) Pte. N/A N/A S7TFLKD0ZWWBHLSCAD37 SG 0.00000000 Copeland Capital Management, LLC N/A 000135822 549300F580MX332YTG45 0.00000000 Prime Dealer Services Corp. 8-47025 000036142 549300U1ZGT51W4F9866 0.00000000 MEMX Holdings LLC N/A N/A N/A 0.00000000 Morgan Stanley Saudi Arabia Company N/A N/A 549300JYPS6Z0I1BVB86 SA 0.00000000 Morgan Stanley Smith Barney LLC 8-68191 000149777 7PDDXEMZ0ZV0CEDU4D16 0.00000000 Morgan Stanley Capital Services LLC N/A N/A I7331LVCZKQKX5T7XV54 0.00000000 Morgan Stanley Senior Funding, Inc. N/A N/A XRR2REEVVJS58CENNG14 0.00000000 Morgan Stanley Wealth Management Canada Inc. N/A N/A 549300VVMTKCWZUZVJ61 CA 0.00000000 Limited Liability Company 'Morgan Stanley Bank' N/A N/A KXR3XGBYJIDK7XYBRF48 RU 0.00000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 13133.68000000 13133.68000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 117206151.08000000 BNP Paribas Securities Corp. 8-32682 000015794 RCNB6OTYUAMMP879YW96 255124705.11000000 State Street Bank and Trust Company N/A N/A 571474TGEMMWANRLN572 305957523.55000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 179635628.05000000 BMO Capital Markets Corp. 8-34344 000016686 RUC0QBLBRPRCU4W1NE59 25385666.35000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 396573056.24000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 488154859.86000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 302448242.96000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 61269983.35000000 Euroclear Bank N/A N/A 549300OZ46BRLZ8Y6F65 BE 27827988.28000000 2235174098.27000000 N 268133141.74000000 Uncommitted 750000000.00000000 N Committed 300000000.00000000 N N N N true INTERNAL CONTROL RPT 2 NCEN_811-03870_43613366_1222.htm morganstanleyusgovernmentsec.htm - Generated by SEC Publisher for SEC Filing

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Trustees of

Morgan Stanley U.S. Government Securities Trust

 

In planning and performing our audit of the financial statements of Morgan Stanley U.S. Government Securities Trust (the “Fund”) as of and for the year ended December 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

 

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.

 


 

However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2022.

 

This report is intended solely for the information and use of management and the Board of Trustees of Morgan Stanley U.S. Government Securities Trust, and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

 

 

 

/s/ ERNST & YOUNG LLP

 

                                                                                                                                                                                                                                                           

                                                                                     

Boston, Massachusetts

February 28, 2023